Earnings Play: Canopy Growth Corporation
Jason Lubin November 7, 2020 3:20 AM
Cannabis stocks got a boost after 5 states legalized marijuana.
On Monday, before market, Canopy Growth Corporation (CGC) is anticipated to release third quarter revenue of approximately $119.1 million vs. $76.6 million last year. The company cultivates and sells medicinal and recreational cannabis, and on November 4th, ABC News reported that 5 states passed marijuana legalization measures.
Looking at a daily chart, in logarithmic scale, Canopy's stock price has been in a short-term uptrend since the beginning of October. The RSI is bullish and currently just below overbought territory. The simple moving averages (SMA) have just turned bullish, as the 20-day SMA is above the 50-day SMA, and the 50-day SMA is above the 200-day SMA. On the chart traders can see that after the election on November 3rd Canopy's stock price became very volatile and has gapped at each market open since. Price will likely continue to rise towards the 2020 high of $26.00. At around $26.00 the stock will probably sell off a bit as speculators take some profits, and price will likely pull back to the 20-day SMA around the bullish trendline. If price can manage to hold above the bullish trendline then it could be a chance for late comers to jump on for a retest of $26.00. If price breaks out to the upside of 26.00, then its next targets would be $29.60 and 34.30, levels last reached in 2019. On the flip side, if Canopy pulls back to the bullish trendline and breaks below it, then a rebound could occur at around 17.40. If price cant hold at 17.40 then it could dip to 15.50, which would be a bearish signal as price be below the 200-day SMA. If price cant find footing on 15.50, then it will likely decline further to 13.80.
Source: GAIN Capital, TradingView
From time to time, StoneX Financial Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.
As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.